GLIQUNAC: a powerful antioxidant with NAC, Glycine, and Quercetin to promote glutathione synthesis GLIQUNAC is a food supplement in tablets, each containing 600 mg of N-Acetyl-L-Cysteine (NAC), 400 mg of Glycine, and 50 mg of Quercetin
Effect of D3 dopamine receptors blockade on the cognitive effects of angiotensin IV in rats
Recent studies show: Sunlight can pass through the human body, improving mitochondrial function
Blue Remove combines zeolite, curcumin, and nattokinase
The Korean Journal of Pain
After decades with no disease-modifying drug, 20242026 finally delivered the first targeted therapies: Novartis ianalumab met both NEPTUNUS-1 & NEPTUNUS-2 Phase 3 endpoints and won FDA Breakthrough Therapy status in Jan 2026, and J&Js nipocalimab was positive in the Phase 2 DAHLIAS trial ( The Lancet )